mPATH
PrivateLast Round
Seed
Oct 21, 2024
Est. Valuation
$2M
Total Funding Raised
$7.83M
Company Overview
mPATH is a digital healthcare company that provides a cloud-based platform to help healthcare organizations automate patient outreach and navigation for cancer screenings.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mPATH Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
mPATH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 21, 2024 | ||||
| Grant | Jul 1, 2024 | ||||
| Angel | Mar 5, 2024 | ||||
| Seed | Jun 21, 2022 | ||||
| Accelerator | Jan 25, 2021 |
Key People
Founding team and executive leadership
mPATH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Full Circle | Seed |
| TBD Angels | Seed |
| National Cancer Institute | Grant, Angel |
| Graham & Walker | Seed |
| Next Act Fund | Seed |
| Brightside Venture Capital | Seed |
| Next Frontier Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2025
Partnered with NC DHHS to increase cancer screening.
- Mar 6, 2025
Winner of the HLTH Techquity Case Study Awards.
mPATH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about mPATH's valuation, stock price, and market status.